S-nitroso human serum albumin improves oxygen metabolism during reperfusion after severe myocardial ischemia

Pharmacology

Volumn 72, Issue 2, 2004, Pages 106-112

  Dworschak, Martin ^a   Franz, Maximilian ^b   Hallström, Seth ^c   Semsroth, Severin ^b   Gasser, Harald ^b   Haisjackl, Markus ^a   Podesser, Bruno K ^b   Malinski, Tadeusz ^d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c Birkmayer Laboratories ^*  (Austria)

^d OHIO UNIVERSITY   (United States)

Author keywords

Controlled reperfusion; Heart preservation; Ischemia reperfusion; Myocardial blood flow; Myocardial oxygen metabolism; Nitric oxide; Postischemic contractile function

Indexed keywords

HUMAN SERUM ALBUMIN; LACTIC ACID; NITROSO HUMAN SERUM ALBUMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DISEASE SEVERITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; TREATMENT OUTCOME;

ANIMALS; CORONARY CIRCULATION; HEMODYNAMIC PROCESSES; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSO COMPOUNDS; OXYGEN CONSUMPTION; PROSPECTIVE STUDIES; SERUM ALBUMIN, BOVINE; SWINE;

EID: 4444314261     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079139     Document Type: Article

References (19)

1. Pinsky DJ, Oz MC, Koga S, Taha Z, Broekman MJ, Marcus AJ, Liao H, Naka Y, Brett J, Cannon PJ, et al: Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest 1994;93:2291-2297.
2. Huk I, Nanobashvili J, Neumayer C, Punz A, Mueller M, Afkhampour K, Mittlboeck M, Losert U, Polterauer P, Roth E, Patton S, Malinski T: L-Arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 1997;96:667-675.
3. Takano H, Tang XL, Qui Y, Guo Y, French BA, Bolli R: Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res 1998;83:73-84.
4. Nakano A, Liu GS, Heusch G, Downey JM, Cohen MV: Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol 2000;32:1159-1167.
5. Kupatt C, Habazettl H, Zahler S, Weber C, Becker BF, Messmer K, Gerlach E: ACE-inhibition prevents postischemic coronary leukocyte adhesion and leucocyte-dependent reperfusion injury. Cardiovasc Res 1997;36:386-394.
6. Mohara J, Oshima K, Tsutsumi H, Takeyoshi I, Matsumoto K, Morishita Y: FK409 ameliorates ischemia-reperfusion injury in heart transplantation following 12-hour cold preservation. J Heart Lung Transplant 2000;19:694-700.
7. Rakhit RD, Mojet MH, Marber MS, Duchen MR: Mitochondria as targets for nitric oxideinduced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes. Circulation 2001;103:2617-2623.
8. Hallstöm S, Gasser H, Neumayr C, Fugl A, Nanobashvili J, Jakubowski A, Huk I, Schlag G, Malinski T: S-nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release. Circulation 2002;105:3032-3038.
9. Vinten-Johansen J, Ronson RS: Harnessing the cardioprotective potential of nitric oxide in nonsurgical and surgical ischemic-reperfusion injury; in Beyersdorf F (ed): Ischemic-Reperfusion Injury in Cardiac Surgery. Medical Intelligence Unit 23. Georgetown/TX, Landes Bioscience, 2001, pp 2-27.
10. 1 reduces ischemia/reperfusion injury by normalizing nitric oxide and superoxide release. Shock 2000;14:234-242.
11. Pietersen HG, Langenberg CJ, Geskes G, Kester A, de Lange S, Van der Vusse GJ, Wagenmakers AJ, Soeters PB: Myocardial substrate uptake and oxidation during and after routine cardiac surgery. J Thorac Cardiovasc Surg 1999;118:71-80.
12. Smolenski RT, Seymour AM, Yacoub MH: Dynamics of energy metabolism in the transplanted human heart during reperfusion. J Thorac Cardiovasc Surg 1994;108:938-945.
13. Bauersachs J, Bouloumié A, Fraccarollo D, Hu K, Busse R, Ertl G: Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression. Role of enhanced vascular superoxide production. Circulation 1999;100:292-298.
14. Sherman AJ, Davis CA, Klocke FJ, Harris KR, Srinivasan G, Yaacoub AS, Quinn DA, Ahlin KA, Jang JJ: Blockade of nitric oxide synthesis reduces myocardial oxygen consumption in vivo. Circulation 1997;95:1328-1334.
15. Görge G, Chatelain P, Schaper J, Lerch R: Effect of increasing degrees of ischemic injury on myocardial oxidative metabolism early after reperfusion in isolated rat hearts. Circ Res 1991;68:1681-1692.
16. Stahl LD, Weiss HR, Becker LC: Myocardial oxygen consumption, oxygen supply/demand heterogeneity, and microvascular patency in regionally stunned myocardium. Circulation 1988;77:865-872.
17. Amrani M, Shirvani R, Allen NJ, Ledingham S, Yacoub MH: Enhancement of low coronary reflow improves postischemic myocardial function. J Thorac Cardiovasc Surg 1992;104:1375-1382.
18. Kupatt C, Zahler S, Seligmann C, Massoudy P, Becker BF, Gerlach E: Nitric oxide mitigates leukocyte adhesion and vascular leak after myocardial ischemia. J Mol Cell Cardiol 1996;28:643-654.
19. Lefer DJ, Scalia R, Campbell B, Nossuli T, Hayward R, Salamon M, Grayson J, Lefer AM: Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest 1997;99:684-691.